Hematologic Disorders

Sep 24, 2021| Posted in: Hematologic Disorders, News, Regulations, Treatment

FDA Approves Ruxolitinib to Treat Chronic GVHD

The FDA has approved ruxolitinib (Jakafi)  to treat…
Sep 22, 2021| Posted in: Cancers, Hematologic Disorders, Treatment

Factors That Impact Treatment Decisions in Elderly Individuals With AML

Dr. Melissa Loh discusses the many factors that…
Sep 21, 2021| Posted in: Cancers, Drug Development, Hematologic Disorders

Will Cilta-Cell Be the Next CAR T-Cell Approval in Multiple Myeloma?

Saad Usmani, MD at Levine Cancer Institute discusses…
Aug 23, 2021| Posted in: Cancers, Hematologic Disorders

Overview of Sarcomas

Roman Grosiberg, MD, Medical Oncologist and Director of…

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

TTR Amyloidosis CME Program

Morie A Gertz, MD, MACP provides an overview of TTR Amyloidosis – including how to shorten individuals’ diagnostic journey and the time till they access treatment which might improve their quality of life or even prevent disease progression – through these brief courses that are certified for CME credit.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

Hematologic Disorders